SCHEMBL27440345

SCHEMBL27440345

Cc1cccc(Cn2cc(/C=C(\C#N)C(=O)O)c3cccnc32)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 4/20 0.60
▸ SNCA P37840 4/20 0.60
▸ ENPP2 Q13822 1/20 0.50
▸ ALDH1A1 P00352 4/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ LMNA P02545 2/20 0.45
▸ THRB P10828 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ ELANE P08246 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CRHBP P24387 1/20 0.41
▸ CRHR2 Q13324 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PTGDR2 Q9Y5Y4 2/20 0.41
▸ CNR1 P21554 1/20 0.40
▸ CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27440679 0.92 APP (0.58) APPSNCAENPP2ALDH1A1MEN1
SCHEMBL27440181 0.89 SNCA (0.76) APPSNCAENPP2ALDH1A1MEN1
SCHEMBL24164332 0.89 APP (0.60) APPSNCAENPP2ALDH1A1LMNA
SCHEMBL27440336 0.89 SNCA (0.63) APPSNCAENPP2ALDH1A1MEN1
SCHEMBL32677383 0.86 APP (0.57) APPSNCAENPP2ALDH1A1LMNA
SCHEMBL27440358 0.86 SNCA (0.57) APPSNCAENPP2ALDH1A1MEN1
SCHEMBL27440758 0.86 SNCA (0.57) APPSNCAENPP2ALDH1A1MEN1
SCHEMBL25424902 0.86 APP (0.57) APPSNCAENPP2ALDH1A1LMNA
SCHEMBL31169581 0.86 APP (0.57) APPSNCAENPP2ALDH1A1LMNA
SCHEMBL26552405 0.86 APP (0.52) APPSNCAENPP2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145369-A1 COMPOUNDS FOR TREATMENT OF HAIR LOSS PELAGE PHARMACEUTICALS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback